Form 4: Avidity Biosciences Executive Exercises Options and Sells Shares Under 10b5-1 Plan

Teresa McCarthy, Chief Human Resources Officer of Avidity Biosciences, exercised stock options and sold 25,000 shares of common stock on October 16, 2024, under a pre-arranged trading plan.

Summary

• On October 16, 2024, Teresa McCarthy, the Chief Human Resources Officer of Avidity Biosciences, exercised stock options to acquire 25,000 shares of common stock at a price of $14.22 per share.
• Simultaneously, McCarthy sold 25,000 shares of Avidity Biosciences common stock at a weighted-average price of $48.5204, with individual sales ranging from $46.56 to $49.04.
• These transactions were executed under a Rule 10b5-1 trading plan adopted on June 12, 2024.
• Following these transactions, McCarthy directly owns 94,018 shares of Avidity Biosciences common stock and holds options for 107,500 shares.

Sentiment

Score: 5

Explanation: The sentiment is neutral. The filing simply reports transactions under a pre-existing plan, which doesn't inherently indicate positive or negative sentiment about the company's prospects.

Positives

• The transactions were executed under a pre-arranged 10b5-1 trading plan, which can reassure investors that the sales were not based on insider information.

Industry Context

Executive stock sales are a common occurrence in publicly traded companies. Monitoring these transactions can provide insights into management's perspective on the company's valuation and future prospects. The use of a 10b5-1 plan is a standard practice to avoid accusations of insider trading.

Comparison to Industry Standards

• Executive compensation packages often include stock options as a way to align management's interests with those of shareholders.
• Rule 10b5-1 trading plans are widely used by corporate insiders to sell shares over time, mitigating the risk of insider trading allegations.
• The vesting schedule of the options (1/48th per month) is a typical arrangement to incentivize long-term commitment.

Stakeholder Impact

• The stock sale could have a minor impact on shareholders, potentially creating slight downward pressure on the stock price in the short term.
• The exercise of stock options dilutes existing shareholders' equity to a small degree.

Key Dates